Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

14.45
Delayed Data
As of Jun 23
 0.00 / 0.00%
Today’s Change
8.06
Today|||52-Week Range
17.20
+18.93%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 22.00, with a high estimate of 25.00 and a low estimate of 17.00. The median estimate represents a +52.25% increase from the last price of 14.45.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.59
Sales
$8.5M
Reporting Date
Aug 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.53%
 
 
 
 
 
 
Growthannually -738.46%
 
 
 
 
 
 

Sales

Growthquarterly 104.57%
 
 
 
 
 
 
Growthannually -70.26%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.